Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Esposito Pamela | Dec 2, 2024 | Sell | 2,500 | $49 | $120,000 |
| Esposito Pamela | Sep 17, 2024 | Sell | 7,150 | $48.7526 | $350,000 |
| Esposito Pamela | Sep 17, 2024 | Sell | 6,350 | $47.7456 | $300,000 |
| Albers Jeffrey W. | Aug 26, 2024 | Sell | 5,000 | $49.1017 | $250,000 |
| BAKER JULIAN | Aug 21, 2024 | Buy | 2,246,587 | $40.7499 | $92M |
| BAKER JULIAN | Aug 21, 2024 | Buy | 347,572 | $40.7499 | $14M |
| BIOTECHNOLOGY VALUE FUND L P | Aug 20, 2024 | Buy | 201,546 | $40.7499 | $8.2M |
| BIOTECHNOLOGY VALUE FUND L P | Aug 20, 2024 | Buy | 156,742 | $40.7499 | $6.4M |
| BAKER JULIAN | Aug 20, 2024 | Buy | 1 | $46.41 | $46 |
| Gollob Jared | Jul 16, 2024 | Sell | 13,281 | $45.5931 | $610,000 |
| Gollob Jared | Jul 16, 2024 | Sell | 9,864 | $46.0965 | $450,000 |
| Gollob Jared | Jul 15, 2024 | Sell | 16,455 | $45.1489 | $740,000 |
| Booth Bruce | Jul 9, 2024 | Sell | 183,868 | $38.48 | $7.1M |
| Booth Bruce | Jul 9, 2024 | Sell | 96,386 | $39.26 | $3.8M |
| Booth Bruce | Jul 9, 2024 | Sell | 41,763 | $37.41 | $1.6M |
| Booth Bruce | Jul 9, 2024 | Sell | 38,606 | $38.48 | $1.5M |
| Booth Bruce | Jul 9, 2024 | Sell | 28,718 | $36.4 | $1M |
| Booth Bruce | Jul 9, 2024 | Sell | 24,449 | $35.57 | $870,000 |
| Booth Bruce | Jul 9, 2024 | Sell | 20,238 | $39.26 | $790,000 |
| Booth Bruce | Jul 9, 2024 | Sell | 8,769 | $37.41 | $330,000 |
| Booth Bruce | Jul 9, 2024 | Sell | 6,030 | $36.4 | $220,000 |
| Booth Bruce | Jul 9, 2024 | Sell | 5,133 | $35.57 | $180,000 |
| Booth Bruce | Jun 13, 2024 | Sell | 8,430 | $34.98 | $290,000 |
| Booth Bruce | Jun 13, 2024 | Sell | 1,770 | $34.98 | $62,000 |
| Booth Bruce | Jun 12, 2024 | Sell | 11,838 | $35.35 | $420,000 |
| Booth Bruce | Jun 12, 2024 | Sell | 2,485 | $35.35 | $88,000 |
| Booth Bruce | Jun 12, 2024 | Sell | 1,997 | $36.02 | $72,000 |
| Booth Bruce | Jun 12, 2024 | Sell | 420 | $36.02 | $15,000 |
| Horobin Joanna | Jun 7, 2024 | Sell | 6,313 | $33.1071 | $210,000 |
| Horobin Joanna | Jun 7, 2024 | Sell | 2,187 | $32.6451 | $71,000 |
| Chadwick Jeremy G | May 23, 2024 | Sell | 2,575 | $34.9921 | $90,000 |
| Booth Bruce | Mar 15, 2024 | Sell | 49,591 | $40.62 | $2M |
| Booth Bruce | Mar 15, 2024 | Sell | 10,411 | $40.62 | $420,000 |
| Booth Bruce | Mar 15, 2024 | Sell | 8,126 | $39.31 | $320,000 |
| Booth Bruce | Mar 15, 2024 | Sell | 1,714 | $39.31 | $67,000 |
| Booth Bruce | Mar 15, 2024 | Sell | 1,593 | $41.23 | $66,000 |
| Booth Bruce | Mar 15, 2024 | Sell | 329 | $41.23 | $14,000 |
| Booth Bruce | Mar 14, 2024 | Sell | 34,473 | $39.73 | $1.4M |
| Booth Bruce | Mar 14, 2024 | Sell | 10,846 | $40.66 | $440,000 |
| Booth Bruce | Mar 14, 2024 | Sell | 7,292 | $39.73 | $290,000 |
| Booth Bruce | Mar 14, 2024 | Sell | 2,233 | $40.66 | $91,000 |
| Booth Bruce | Mar 14, 2024 | Sell | 781 | $41.51 | $32,000 |
| Booth Bruce | Mar 14, 2024 | Sell | 154 | $41.51 | $6,400 |
| Atlas Venture Fund X, L.P. | Mar 13, 2024 | Sell | 108,404 | $42.19 | $4.6M |
| Booth Bruce | Mar 13, 2024 | Sell | 108,404 | $42.19 | $4.6M |
| Atlas Venture Fund X, L.P. | Mar 13, 2024 | Sell | 22,779 | $42.19 | $960,000 |
| Booth Bruce | Mar 13, 2024 | Sell | 22,779 | $42.19 | $960,000 |
| Atlas Venture Fund X, L.P. | Mar 13, 2024 | Sell | 6,686 | $42.84 | $290,000 |
| Atlas Venture Fund X, L.P. | Mar 13, 2024 | Sell | 1,386 | $42.84 | $59,000 |
| Booth Bruce | Mar 13, 2024 | Sell | 6,686 | $42.84 | $290,000 |
| Booth Bruce | Mar 13, 2024 | Sell | 1,386 | $42.84 | $59,000 |
| Atlas Venture Fund X, L.P. | Mar 12, 2024 | Sell | 126,066 | $41.94 | $5.3M |
| Booth Bruce | Mar 12, 2024 | Sell | 126,066 | $41.94 | $5.3M |
| Atlas Venture Fund X, L.P. | Mar 12, 2024 | Sell | 26,452 | $41.94 | $1.1M |
| Booth Bruce | Mar 12, 2024 | Sell | 26,452 | $41.94 | $1.1M |
| Atlas Venture Fund X, L.P. | Mar 12, 2024 | Sell | 8,581 | $42.52 | $360,000 |
| Atlas Venture Fund X, L.P. | Mar 12, 2024 | Sell | 1,819 | $42.52 | $77,000 |
| Booth Bruce | Mar 12, 2024 | Sell | 8,581 | $42.52 | $360,000 |
| Booth Bruce | Mar 12, 2024 | Sell | 1,819 | $42.52 | $77,000 |
| Atlas Venture Fund X, L.P. | Mar 11, 2024 | Sell | 37,180 | $42.77 | $1.6M |
| Booth Bruce | Mar 11, 2024 | Sell | 37,180 | $42.77 | $1.6M |
| Atlas Venture Fund X, L.P. | Mar 11, 2024 | Sell | 7,837 | $42.77 | $340,000 |
| Atlas Venture Fund X, L.P. | Mar 11, 2024 | Sell | 5,122 | $43.42 | $220,000 |
| Atlas Venture Fund X, L.P. | Mar 11, 2024 | Sell | 1,045 | $43.42 | $45,000 |
| Booth Bruce | Mar 11, 2024 | Sell | 7,837 | $42.77 | $340,000 |
| Booth Bruce | Mar 11, 2024 | Sell | 5,122 | $43.42 | $220,000 |
| Booth Bruce | Mar 11, 2024 | Sell | 1,045 | $43.42 | $45,000 |
| Gollob Jared | Mar 4, 2024 | Sell | 2,022 | $41.4135 | $84,000 |
| Gollob Jared | Mar 4, 2024 | Sell | 1,106 | $42.3924 | $47,000 |
| Jacobs Bruce N. | Mar 4, 2024 | Sell | 2,378 | $41.4135 | $98,000 |
| Jacobs Bruce N. | Mar 4, 2024 | Sell | 1,301 | $42.3924 | $55,000 |
| Gollob Jared | Mar 4, 2024 | Sell | 216 | $43.2564 | $9,300 |
| Jacobs Bruce N. | Mar 4, 2024 | Sell | 255 | $43.2564 | $11,000 |
| Gollob Jared | Feb 27, 2024 | Sell | 400 | $45 | $18,000 |
| Albers Jeffrey W. | Feb 21, 2024 | Sell | 4,385 | $39.0483 | $170,000 |
| Albers Jeffrey W. | Feb 20, 2024 | Sell | 615 | $39.0746 | $24,000 |
| Albers Jeffrey W. | Jan 23, 2024 | Sell | 10,000 | $30.047 | $300,000 |
| BIOTECHNOLOGY VALUE FUND L P | Jan 5, 2024 | Buy | 550,425 | $25.2499 | $14M |
| BIOTECHNOLOGY VALUE FUND L P | Jan 5, 2024 | Buy | 375,856 | $25.2499 | $9.5M |
| BIOTECHNOLOGY VALUE FUND L P | Jan 5, 2024 | Buy | 52,733 | $25.2499 | $1.3M |
| Chiniara Ellen | Jan 4, 2024 | Sell | 3,295 | $22.5844 | $74,000 |
| BIOTECHNOLOGY VALUE FUND L P | Nov 3, 2023 | Buy | 103,885 | $14.0689 | $1.5M |
| BIOTECHNOLOGY VALUE FUND L P | Nov 3, 2023 | Buy | 83,708 | $14.0689 | $1.2M |
| BIOTECHNOLOGY VALUE FUND L P | Nov 3, 2023 | Buy | 10,106 | $14.0689 | $140,000 |
| BIOTECHNOLOGY VALUE FUND L P | Nov 2, 2023 | Buy | 132,016 | $11.6444 | $1.5M |
| BIOTECHNOLOGY VALUE FUND L P | Nov 2, 2023 | Buy | 57,618 | $11.6444 | $670,000 |
| BIOTECHNOLOGY VALUE FUND L P | Nov 2, 2023 | Buy | 26,772 | $11.6444 | $310,000 |
| Gollob Jared | Mar 2, 2023 | Sell | 1,001 | $30.8774 | $31,000 |
| Jacobs Bruce N. | Mar 2, 2023 | Sell | 1,056 | $30.8774 | $33,000 |
| Caughey Elaine | Mar 2, 2023 | Sell | 550 | $30.8774 | $17,000 |
| Caughey Elaine | Mar 2, 2023 | Sell | 164 | $31.3973 | $5,100 |
| Gollob Jared | Mar 2, 2023 | Sell | 297 | $31.3973 | $9,300 |
| Jacobs Bruce N. | Mar 2, 2023 | Sell | 314 | $31.3973 | $9,900 |
| Booth Bruce | Jan 12, 2023 | Sell | 77,128 | $30.29 | $2.3M |
| Booth Bruce | Jan 12, 2023 | Sell | 21,592 | $30.29 | $650,000 |
| Atlas Venture Fund X, L.P. | Jan 12, 2023 | Sell | 77,128 | $30.29 | $2.3M |
| Atlas Venture Fund X, L.P. | Jan 12, 2023 | Sell | 21,592 | $30.29 | $650,000 |
| BIOTECHNOLOGY VALUE FUND L P | Jan 12, 2023 | Buy | 15,912 | $31.2426 | $500,000 |
| BIOTECHNOLOGY VALUE FUND L P | Jan 12, 2023 | Buy | 2,985 | $31.2426 | $93,000 |
| Booth Bruce | Jan 11, 2023 | Sell | 21,683 | $29.96 | $650,000 |
| Atlas Venture Fund X, L.P. | Jan 11, 2023 | Sell | 21,683 | $29.96 | $650,000 |
| BIOTECHNOLOGY VALUE FUND L P | Jan 11, 2023 | Buy | 11,149 | $29.8869 | $330,000 |
| BIOTECHNOLOGY VALUE FUND L P | Jan 11, 2023 | Buy | 10,961 | $29.8869 | $330,000 |
| Booth Bruce | Jan 11, 2023 | Sell | 6,071 | $29.96 | $180,000 |
| Atlas Venture Fund X, L.P. | Jan 11, 2023 | Sell | 6,071 | $29.96 | $180,000 |
What's the latest insider transaction for Kymera Therapeutics?
The most recent insider transaction for Kymera Therapeutics was conducted by Esposito Pamela, who sold 2,500 shares on December 2, 2024 at a price of $49.00 per share.
Which insider bought the most KYMR stock over the last two years?
BAKER JULIAN has bought the most KYMR stock in the last 2 years, with a total value of $106M.
Which insider has sold the most KYMR stock over the last two years?
Booth Bruce has sold the most KYMR stock in the last 2 years, with a total value of $42M.
What is the total value of insider transactions for Kymera Therapeutics (KYMR) in the last 2 years?
According to our estimates, the total value of insider transactions for Kymera Therapeutics in the last 2 years is positive, amounting to $86M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Kymera Therapeutics' market confidence?
Over the last 2 years, insider transactions for Kymera Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
